Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Beat the Dow Jones With CRISPR Therapeutics Stock

TheMotleyFool

0 0

Beat the Dow Jones With CRISPR Therapeutics Stock: https://g.foolcdn.com/editorial/images/721067/gettyimages-research-team-smiles-in-lab.jpg

Back in 2020, CRISPR Therapeutics (NASDAQ: CRSP) left the Dow Jones Industrial Average (DJIA) in the dust. The stock soared more than 150%, while the DJIA delivered a modest 7% increase. Investors were excited about biotech companies -- and CRISPR's gene-editing technology caught their attention.

But as economic woes accumulated over the past couple of years, investors fled stocks they perceived as risky. And CRISPR, with a newish technology that hadn't yet resulted in a commercialized product, fell out of favor.

The economic situation remains tumultuous right now. At the same time, CRISPR has a major catalyst ahead that could help it beat the Dow Jones this year and even over time. Let's take a closer look.

Source Fool.com

Like: 0

CRSP

Share